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Abstract The non-essential amino acid L-serine was shown to
be required to support the survival of rat cerebellar Purkinje
neurons because of lack of the expression of the L-serine bio-
synthesis enzyme 3-phosphoglycerate dehydrogenase in them. In
the present study, we investigated L-[3H]serine uptake in pri-
mary cultures of neurons and astrocytes from the rat telenceph-
alon. In both neurons and astrocytes, L-[3H]serine uptake was
dependent on temperature and Na+ ions, and exhibited a single
component of high-a⁄nity uptake sites (Km = 15.0 and 17.2 WM
for neurons and astrocytes, respectively). Kinetic analysis of
L-[3H]serine uptake also revealed that the uptake into neurons
was faster than that into astrocytes. The selectivity of inhibition
by amino acids of the L-[3H]serine uptake resembled that of the
system ASC transporters ASCT1 and ASCT2. Neutral amino
acids L-alanine, L-serine, L-cysteine, and L-threonine strongly
inhibited the uptake by both cell types. Furthermore, in astro-
cytes, but not in neurons, L-valine and L-proline also inhibited
L-[3H]serine uptake. Neither K-methyl aminoisobutyric acid (a
system A-speci¢c substrate) nor 2-aminobicyclo(2,2,1)heptane-
2-carboxylic acid (a system L-speci¢c substrate) inhibited the
uptake of L-[3H]serine in both neurons and astrocytes. Expres-
sion of ASCT transporters in both neurons and astrocytes was
examined by use of reverse transcriptase polymerase chain re-
action and immunoblot analysis. Whereas transcripts (mRNAs)
of both ASCT1 and ASCT2 transporters were detected in as-
trocytes, only the mRNA of the former subtype was detected in
neurons. Immunoblot analysis con¢rmed the presence of ASCT1
in both neurons and astrocytes. These ¢ndings indicate that
neurons accumulate a high level of L-serine by using a Na+-
dependent, high-a⁄nity transport system, operating predomi-
nantly through the ASCT1 transporter subtype.
; 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
L-Serine is well-known to be a non-essential amino acid that
can be synthesized by many cells. A recent study demon-
strated that cerebellar Purkinje neurons had an essential re-
quirement for extracellular L-serine to support their survival
[1]. L-Serine is a key amino acid for the synthesis of the neuro-
transmitters glycine and D-serine in the brain [2,3], in addition
to being a precursor for the biosynthesis of various protein
and membrane lipid molecules. In the central nervous system,
glycine and D-serine were shown to be especially important by
acting as co-agonists in the regulation of N-methyl-D-aspar-
tate receptor function [4^7]. L-Serine is synthesized from the
glycolytic intermediate 3-phosphoglycerate by three enzymes,
the initiating enzyme being 3-phosphoglycerate dehydrogenase
(3PGDH) [8]. Recently, immunohistochemistry and in situ
hybridization studies on 3PGDH demonstrated that 3PGDH
expression was down-regulated in neurons of the developing
mouse brain but highly expressed in astroglia [9]. In particu-
lar, cerebellar Purkinje neurons showed no detectable mRNA
or immunoreactivity for 3PGDH [1,9]. Therefore, those
3PGDH-negative neurons require speci¢c systems for the up-
take of extracellular L-serine to support their survival and
development.
The uptake of L-serine occurs through several transport
systems, including Naþ-dependent transporters such as neu-
tral amino acid transporter system ASC and system A, and
Naþ-independent transporters, system L and system asc. Sys-
tem ASC transporters ASCT1 and ASCT2 have been identi-
¢ed and cloned from humans and mice [10^13]. Although the
expression of the ASCT1, but not ASCT2, subtype of neutral
amino acid transporter has been detected in brain, detailed
aspects and its roles in L-serine transport in the brain remain
to be clari¢ed. In the present report, we provide a detailed
characterization of L-serine transport into neurons and astro-
cytes, which is e¡ected by Naþ-dependent and high-a⁄nity
transporters.
2. Materials and methods
2.1. Materials
L-[3H]Serine (speci¢c radioactivity 851.0 GBq/mmol) was purchased
from NEN Life Science Products (Boston, MA, USA). 2-Methyl-
aminoisobutyrate (MeAIB), 2-aminobicyclo(2,2,1)heptane-2-carbox-
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ylic acid (BCH), and all amino acids were obtained from Sigma-Al-
drich. All other reagents used were analytical grade.
2.2. Cell cultures
Primary neuronal cell cultures were prepared from the fetal rat
telencephalon (embryonic day 18 or 19) as described before [14]. Fol-
lowing dissociation for 15^20 min at 37‡C with 0.25% trypsin (Difco)
in Ca2þ-, Mg2þ-free phosphate-bu¡ered saline containing 0.02%
DNase I (Sigma), the cells were mechanically dispersed by repetitive
pipetting and ¢ltered through a nylon mesh. They were then rinsed
with a de¢ned culture medium, Dulbecco’s modi¢ed Eagle’s medium
(DMEM), and plated on poly-L-lysine-coated wells of 96-well plates at
a ¢nal density of 0.5^1.5U106 cells/ml. The cultures were maintained
for 7 days in DMEM supplemented with 1 mg/ml bovine serum al-
bumin (BSA), 10 Wg/ml insulin, 1 nM 3,3P,5-triiodo-L-thyronine,
0.1 mg/ml human transferrin, 1 Wg/ml aprotinin, 100 WM putrescine,
1 mM sodium pyruvate, 10 nM progesterone, 30 nM selenium, 0.1 mg/
ml streptomycin sulfate, and 50 U/ml penicillin G potassium salt
(Meiji Seika, Tokyo, Japan) in a humidi¢ed atmosphere of 5% CO2
in air at 37‡C. More than 95% of the cultured cells were negative for
immunoreaction with anti-glial ¢brillary acidic protein antibody (data
not shown).
Astrocyte cultures were derived from the same preparation as the
above described method preparing neuronal cultures. The dispersed
cells were plated on poly-L-lysine-coated wells of 96-well plates and
maintained for 14^21 days in DMEM containing 5% fetal calf serum
and 5% horse serum supplemented with 0.1 mg/ml streptomycin sul-
fate and 50 U/ml penicillin G potassium salt.
2.3. L-[3H]Serine uptake experiment
On the day of the experiment, the culture medium was aspirated
from the neuronal or astrocyte cell cultures, and these cells were
washed three times with 0.1 ml of uptake bu¡er containing 5 mM
HEPES-NaOH (or KOH) (pH 7.2), 140 mM NaCl (or choline-Cl),
5 mM KCl, 1 mM KH2PO4, 1.8 mM CaCl2, 0.4 mM MgCl2, and
10 mM glucose. After the cells had been preincubated in the uptake
bu¡er for 30 min at 37‡C, they were incubated at 37‡C for 5 (neuro-
nal) or 10 (astrocytes) min in 0.1 ml of fresh uptake bu¡er supple-
mented with 20 nM (¢nal concentration) L-[3H]serine and di¡erent
amounts of unlabeled amino acids. Uptake was terminated by rapid
removal of the medium followed by quick washes with ice-cold phos-
phate-bu¡ered saline. To measure the amount of L-[3H]serine taken
up into the cells, we added 50 Wl of a 10% sodium dodecyl sulfate
(SDS) solution to each well and solubilized the cells for 1 h at 37‡C.
The radioactivities were measured using a liquid scintillation counter.
Each uptake was represented as the mean of three to four independent
experiments, each done in quadruplicate. Naþ-independent uptake
was carried out by incubation of cells in medium containing choline
chloride instead of NaCl. Protein content was measured using a Brad-
ford protein assay kit (Bio-Rad, Richmond, CA, USA) after the cells
had been solubilized with 0.1 M NaOH.
2.4. RT-PCR analysis of ASCT transporter
Expression of ASCT1 and ASCT2 transcripts in neurons and as-
trocytes was examined by reverse transcriptase polymerase chain re-
action (RT-PCR). Total RNA from cultured rat primary neurons and
astrocytes was isolated using a Catrimox-14 RNA Isolation kit (Ta-
KaRa, Osaka, Japan) according to the manufacturer’s protocol.
RT-PCR was performed with an RNA LA PCR kit (TaKaRa). RT
was performed at 50‡C for 30 min, followed by denaturation at 90‡C
for 5 min. PCR ampli¢cation of cDNAs of ASCT1, ASCT2, and
GAPDH (as an internal standard) was then performed for 35 cycles
of 94‡C for 30 s for denaturation, 58‡C for 30 s for primer annealing,
and 72‡C for 2 min for DNA extension. Sequences of the primers for
ASCT1, ASCT2, and GAPDH cDNAs were as follow: for rat
ASCT1: forward primer, 5P-GTTTGCGACGGCTTTTGCGACC-
TG-3P ; reverse primer, 5P-GCATCCCCTTCCACGTTCACCACA-
3P ; product size, 399 bp (GenBank accession number AB103401),
for rat ASCT2: forward primer, 5P-GCGCCTGGGCCCTGC-
TCTTTTT-3P ; reverse primer, 5P-ACAATCTTGCCGGCCACCAG-
GAAC-3P ; product size, 478 bp (GenBank accession number
AJ132846); and for rat GAPDH: forward primer, 5P-GTCAG-
TGCCGGCCTCGTCTCATAG-3P reverse primer 5P-GACCCTT-
TTGGCACCACCCTTCAG-3P ; product size, 380 bp (GenBank ac-
cession number M17701). The PCR ampli¢cation products were
separated on a 3% agarose gel, stained with ethidium bromide, and
visualized under UV irradiation.
2.5. Immunoblotting
Both neuronal and astroglial cells were harvested and lysed in
50 mM Tris^HCl (pH 7.4) bu¡er containing 1 mM EDTA and com-
plete protease inhibitor cocktail (Roche). After the homogenates had
been solubilized in SDS-sample bu¡er and denatured at 100‡C for
3 min, proteins were separated on 10% SDS^polyacrylamide gel elec-
trophoresis gels and then transferred to polyvinylidene di£uoride
membranes (ClearBlot, ATTO, Tokyo, Japan) by electroblotting.
The blots were blocked with 3% BSA and 0.05% Tween 20 in Tris-
bu¡ered saline (TBS) at 4‡C overnight and subsequently incubated at
room temperature for 2.5 h with anti-ASCT1 antibody (1:500; Chem-
icon International, Temecula, CA, USA) in TBS (10 mM Tris^HCl
[pH 7.5], 0.15 M NaCl) containing 0.1% BSA and 0.05% Tween 20
and then incubated with horseradish peroxidase-conjugated goat anti-
rabbit IgG (1:2000) (New England Biolabs) at room temperature for
Fig. 1. Kinetics of L-[3H]serine uptake into neurons (A) and astro-
cytes (B). L-[3H]Serine uptake was assayed in primary neuron or as-
trocyte cultures in uptake bu¡er containing 10 WM L-[3H]serine in
the presence of either 140 mM NaCl or 140 mM choline-Cl. Non-
speci¢c uptake (NS) was measured in the presence of 1 mM L-ser-
ine. Data are the meanQS.E.M. of four independent experiments
done in quadruplicate.
Table 1
Kinetic characteristics of Naþ-dependent uptake of L-[3H]serine in
primary cultures of rat neurons and astrocytes
Km (WM) Vmax (nmol/min/mg protein)
Neurons 15.0Q 1.6 2.456Q0.202
Astrocytes 17.2Q 2.1 1.130Q0.272
Values of Km and Vmax are meansQS.E.M. calculated from a Line-
weaver^Burk plot generated from the data obtained from saturation
experiments using increasing concentrations of L-[3H]serine (3^
50 WM). Naþ-dependent uptake was de¢ned as the di¡erence be-
tween Naþ-containing bu¡er and choline-substituted bu¡er.
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1 h. Immunoreactivities were visualized by the reaction of the blots
with 0.1% diaminobenzidine, 0.012% H2O2, and 0.04% Ni-ammonium
sulfate in 0.2 M Tris^HCl bu¡er, pH 7.5.
2.6. Calculations
Kinetic parameters were calculated by linear regression from Line-
weaver^Burk plots using GraphPad Prism 3.0 software (GraphPad
Software, San Diego, CA, USA). IC50 values of amino acids were
estimated by non-linear regression analysis with Prism 3.0.
3. Results
3.1. L-Serine uptake into primary neurons and astrocytes
At 37‡C, L-[3H]serine was taken up into primary neurons in
a time-dependent manner, and its level reached a plateau after
20 min in the presence of Naþ ions (Fig. 1A). In astrocytes,
L-[3H]serine was also taken up in a time-dependent manner
and still increased linearly after 20 min (Fig. 1B). Further-
more, only a small amount of L-[3H]serine uptake was de-
tected in both primary neurons and astrocytes when choline-
supplemented, Naþ-free uptake bu¡er was used (Fig. 1A,B),
thus suggesting that most of the uptake occurred via a Naþ-
dependent component. The initial rate of L-[3H]serine uptake
into neurons appeared to be faster than that into astrocytes
(t=9.8 min and 88 min, respectively).
L-[3H]Serine uptake was concentration-dependent at 37‡C
(Fig. 2), and was dramatically suppressed at 4‡C (data not
shown). The uptake of L-[3H]serine was saturable and fol-
lowed Michaelis^Menten kinetics, which indicated a single
uptake site. The Km and Vmax values (meanQS.E.M.) were
Fig. 2. Saturation analysis of L-[3H]serine uptake into primary neurons (A) or astrocytes (B). Uptake was measured in the presence of increas-
ing concentrations of L-[3H]serine. C: Lineweaver^Burk plots were used to calculate kinetic parameters, which for the representative experiment
shown were: Km =14.7 WM and Vmax = 2.013 nmol/min/mg protein for neurons, and Km =17.6 WM and Vmax = 1.402 nmol/min/mg protein for
astrocytes.
Table 2
E¡ect of various amino acids on L-[3H]serine uptake into rat neu-
rons and astrocytes in primary culture
Amino acid Astrocytes Neurons
IC50 (WM) IC50 (WM)
L-Ser 40.23Q 10.87 67.03Q 10.88
D-Ser 561.20Q 149.8 s 1000
L-Ala 39.14Q 14.14 90.19Q 12.17
L-Cys 13.18Q 3.47 35.71Q 5.33
L-Thr 37.71Q 8.42 64.64Q 7.15
L-Asn 37.27Q 7.33 141.5Q 14.51
L-Val 76.38Q 22.47 368.00Q 15.20
L-Pro 176.25Q 30.95 519.40Q 61.60
L-Leu 241.00Q 75.42 s 1000
L-Ile 267.9Q 183.6 s 1000
L-Met 334.1Q 38.74 s 1000
L-Gln 574.50Q 77.73 s 1000
Gly 724.9Q 113.8 s 1000
L-Asp s 1000 s 1000
L-Glu s 1000 s 1000
L-Phe s 1000 s 1000
L-Tyr s 1000 s 1000
L-Trp s 1000 s 1000
L-His s 1000 s 1000
L-Arg s 1000 s 1000
L-Lys s 1000 s 1000
MeAIB s 1000 s 1000
BCH s 1000 s 1000
IC50 values were calculated by non-linear regression analysis using
the GraphPad program. Data are the meanQS.E.M. of four to ¢ve
separate experiments.
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15.0Q 1.6 WM and 2.456 nmol/min/mg protein, respectively,
for neurons and 17.2 Q 2.1 WM and 1.130 nmol/min/mg pro-
tein, respectively, for astrocytes (Fig. 2, Table 1).
3.2. Inhibition by various amino acids of the L-[3H]serine
uptake
To evaluate the speci¢city of the uptake system, the inhib-
itory potential of various amino acids on the uptake of
L-[3H]serine was measured for primary neurons and astro-
cytes. The neutral amino acids L-serine, L-alanine, L-cysteine,
and L-threonine, but not glycine, strongly inhibited uptake in
both primary neurons and astrocytes (Table 2). MeAIB and
BCH, which are system A- and system L-speci¢c substrates,
respectively, did not inhibit the uptake. D-Serine was only
weakly inhibitory in astrocytes. The strong inhibition of
L-[3H]serine uptake by L-alanine, L-serine, L-cysteine, L-threo-
nine, and L-asparagine, and the lack of inhibition by MeAIB
and BCH resemble the properties and speci¢city of ASCT-
type transporters. In neurons, L-cysteine, L-serine, L-threonine,
and L-alanine potently inhibited L-[3H]serine uptake, with
IC50 values in the range of 35^90 WM. Furthermore, L-aspar-
agine exhibited an IC50 value of 141 WM, whereas L-valine and
L-proline showed higher IC50 values (368^519 WM). On the
other hand, in astrocytes, L-[3H]serine uptake was also inhib-
ited by L-asparagine and L-valine with high potency (IC50
values, 37^76 WM), in addition to being blocked by the
above-mentioned neutral amino acids (L-cysteine, L-serine,
L-threonine, and L-alanine; IC50 values, 13^40 WM). Also,
L-proline, L-leucine, L-isoleucine, and L-methionine were
weakly inhibitory (IC50 values, 176^334 WM). Other amino
acids were inactive in preventing the uptake of L-[3H]serine
into both neurons and astrocytes. These inhibitory pro¢les of
amino acids indicate that L-[3H]serine may be taken up into
astrocytes by both ASCT1 and ASCT2 transporters.
3.3. Expression of ASCT1 and ASCT2 in primary neurons
and astrocytes
To con¢rm the possible involvement of ASCT1 and ASCT2
transporters in the uptake of L-[3H]serine, we examined the
expression of ASCT1 and ASCT2 at both mRNA and protein
levels. Fig. 3A shows that ASCT1 transcripts were expressed
by both rat neurons and astrocytes in primary culture, as
examined by RT-PCR experiments employing primer pairs
speci¢c for each of the rat ASCT subtypes, but that ASCT2
mRNA could be ampli¢ed only from astrocytes. The weak-
intensity bands of higher MW products in the ASCT2 lane
were not ASCT2-speci¢c fragments as determined by using
sequence analysis. Also, we examined neurons and astrocytes
for the presence of ASCT1 protein (V55 kDa) using anti-
ASCT1 antibody and detected an immunoblot band repre-
senting this protein in samples from both cell types (Fig. 3B).
4. Discussion
This is the ¢rst detailed study of the mechanism of
L-[3H]serine uptake in neurons and astrocytes. In this study,
we reported the kinetics and pharmacological characteristics
of L-[3H]serine uptake sites in rat primary neurons and astro-
cytes. L-Serine and other neutral amino acids, such as L-ala-
nine and L-cysteine, are transported by several carrier systems,
including the Naþ-dependent system ASC and system A, and
also by the Naþ-independent system L and system asc. So far,
it has been reported that ASCT-type transporters predomi-
nantly act in the Naþ-dependent uptake of small neutral ami-
no acids [15]. Our present results clearly indicate that the
major transport component of L-[3H]serine uptake into both
neurons and astrocytes acted mostly (s 95%) in a Naþ-de-
pendent manner and with high a⁄nity (lower Km values).
Therefore, the contribution of the Naþ-independent system
L and system asc to L-[3H]serine uptake may be deemed neg-
ligible. This notion was further con¢rmed by the lack of in-
hibition by BCH, a system L-speci¢c substrate. Moreover,
L-[3H]serine uptake into both neurons and astrocytes was
not inhibited by MeAIB, a system A-speci¢c substrate, indi-
cating that members of the Naþ-dependent system ASC trans-
porter family predominantly contribute to the uptake of
L-[3H]serine in both cell types.
In neurons, inhibition of Naþ-dependent L-[3H]serine up-
take was mostly restricted to that by amino acid substrates
for the ASCT1 transporter subtype, such as L-cysteine,
L-threonine, L-alanine, L-asparagine, and L-serine (in order
of decreasing potency of inhibition). Moreover, the ¢nding
of the expression of ASCT1 mRNA and protein in neurons
Fig. 3. RT-PCR and immunoblot analysis of ASCT expression in
primary cultures of rat neurons and astrocytes. A: ASCT1 and
ASCT2 subtype transcripts in neurons and astrocytes. Ampli¢cation
products speci¢c to ASCT1 (399 bp), ASCT2 (478 bp), and
GAPDH (380 bp), the last as a control, were separated on a 1%
agarose gel, stained with ethidium bromide, and visualized under
UV illumination. The left lane is a molecular size marker. B: Immu-
noblot staining revealing ASCT1 (V55 kDa) expression in neurons
and astrocytes.
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strongly supports this notion. In addition, we further con-
¢rmed little or no expression of ASCT2 mRNA in primary
neurons. Taken together, our data indicate that ASCT1 may
speci¢cally act as the major component of the transport sys-
tem for L-serine uptake into neurons. On the other hand, the
uptake of L-[3H]serine in astrocytes could be also inhibited by
L-valine, L-proline, L-leucine, and L-isoleucine, in addition to
the above-mentioned ASCT1 substrate amino acids. These
inhibitory pro¢les for amino acid selectivity indicate the addi-
tional contribution of the ASCT2 transporter in astrocytes, at
least in part. Indeed, the RT-PCR experiment provided the
evidence that ASCT2 mRNA was expressed in astrocytes, but
not in neurons. The ¢nding of the expression of ASCT2
mRNA in astrocytes is in agreement with a previous report
[16]. Thus the present data clearly demonstrate that L-serine is
transported into primary neurons and astrocytes di¡erently,
i.e. neurons predominantly use ASCT1, whereas astrocytes
may use both ASCT1 and ASCT2 transporters.
L-Serine was taken up more rapidly into neurons than into
astrocytes. Saturation kinetics revealed that the Vmax value
was two-fold greater in neurons than in astrocytes, which
strongly indicates that neurons are capable of accumulating
L-serine from extracellular spaces faster than astrocytes. This
di¡erence in the uptake rate of L-serine between neurons and
astrocytes might correspond to the requirement of neurons for
this amino acid. Indeed, most astrocytes highly expressed the
enzyme of L-serine synthesis, 3PGDH, and thus can produce
L-serine by themselves [1,9]. Thus, our ¢nding of this rapid
uptake of L-serine in neurons indicates that neurons have a
strong need for extracellular L-serine released from neighbor-
ing astrocytes, which cells would contain higher levels of
L-serine. L-Serine has been reported to have a marked e¡ect
on the survival and neurite outgrowth of neurons in culture
[1,17]. Furthermore, it has been shown previously in culture
studies that exogenous L-serine is required for the biosynthesis
of phosphatidyl-L-serine and sphingolipids in hippocampal
neurons [18]. Taken together, the facilitated uptake of L-serine
is thought to be essential for maintaining neuronal function
and survival.
In conclusion, the present study is the ¢rst to demonstrate
that primary neurons and astrocytes di¡erently take up L-ser-
ine by using Naþ-dependent, high-a⁄nity transporter systems
consistent with the ASCT1 and ASCT1/2 transporters, respec-
tively. Furthermore, the data indicate that these di¡erences in
the L-serine transport system between neurons and astrocytes
re£ect the cellular requirement of this amino acid and that
these transport mechanisms may play a key role in the regu-
lation of protein and lipid biosynthesis in neurons, and in
neuronal development and survival.
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